These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 18698244)
1. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244 [TBL] [Abstract][Full Text] [Related]
2. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597 [TBL] [Abstract][Full Text] [Related]
3. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Bergua C; Torregrosa JV; Cofán F; Oppenheimer F Transplant Proc; 2007 Sep; 39(7):2254-5. PubMed ID: 17889155 [TBL] [Abstract][Full Text] [Related]
4. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up. Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463 [TBL] [Abstract][Full Text] [Related]
5. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis. Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931 [TBL] [Abstract][Full Text] [Related]
6. Calcimimetics and bone mineral density in renal transplant patients with persistent secondary hyperparathyroidism. Toro Prieto FJ; Bernal Blanco G; Navarro García M; Cabello Chaves V; Garcíajiménez R; Pereira Palomo P; Gentil Govantes MA Transplant Proc; 2009; 41(6):2144-7. PubMed ID: 19715857 [TBL] [Abstract][Full Text] [Related]
7. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure. Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927 [TBL] [Abstract][Full Text] [Related]
8. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930 [TBL] [Abstract][Full Text] [Related]
9. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation. Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856 [TBL] [Abstract][Full Text] [Related]
10. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527 [TBL] [Abstract][Full Text] [Related]
11. Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet. Wilkie M; Pontoriero G; Macário F; Yaqoob M; Bouman K; Braun J; von Albertini B; Brink H; Maduell F; Graf H; Frazão JM; Bos WJ; Torregrosa V; Saha H; Reichel H; Zani VJ; Carter D; Messa P Nephron Clin Pract; 2009; 112(1):c41-50. PubMed ID: 19365139 [TBL] [Abstract][Full Text] [Related]
12. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292 [TBL] [Abstract][Full Text] [Related]
14. Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism. Lien YH; Silva AL; Whittman D Nephrol Dial Transplant; 2005 Jun; 20(6):1232-7. PubMed ID: 15840675 [TBL] [Abstract][Full Text] [Related]
15. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience. Lucchi L; Carboni C; Stipo L; Malaguti V; Ferrari F; Graziani R; Arletti S; Graziosi C Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793 [TBL] [Abstract][Full Text] [Related]
16. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187 [TBL] [Abstract][Full Text] [Related]
17. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Srinivas TR; Schold JD; Womer KL; Kaplan B; Howard RJ; Bucci CM; Meier-Kriesche HU Clin J Am Soc Nephrol; 2006 Mar; 1(2):323-6. PubMed ID: 17699223 [TBL] [Abstract][Full Text] [Related]